Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,932 | -3,562 | -6,798 | -4,595 | 8,312 |
| Depreciation Amortization | 1,304 | 970 | 641 | 322 | 1,458 |
| Income taxes - deferred | 236 | 236 | -207 | -138 | -3,092 |
| Accounts receivable | 2,317 | 3,069 | -5,308 | 1,746 | -428 |
| Other Working Capital | 793 | 4,258 | 5,932 | 8,084 | -10,589 |
| Other Operating Activity | 1,092 | -288 | 6,318 | -1,231 | 3,021 |
| Operating Cash Flow | $8,674 | $4,683 | $578 | $4,188 | $-1,318 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,420 | 20,420 | N/A | N/A | 5,000 |
| PPE Investments | -1,279 | -854 | -770 | -598 | -1,149 |
| Purchase Of Investment | -15,000 | N/A | N/A | N/A | -20,420 |
| Other Investing Activity | 80 | -25 | -16 | -8 | -142 |
| Investing Cash Flow | $4,221 | $19,541 | $-786 | $-606 | $-16,711 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20,420 | -20,420 | N/A | N/A | N/A |
| Common Stock Issued | 3,626 | N/A | N/A | N/A | 24,666 |
| Financing Cash Flow | $-16,794 | $-20,420 | $N/A | $N/A | $24,666 |
| Exchange Rate Effect | 25 | -29 | -27 | -7 | -114 |
| Beginning Cash Position | 23,634 | 23,634 | 23,634 | 23,634 | 17,111 |
| End Cash Position | 19,760 | 27,409 | 23,399 | 27,209 | 23,634 |
| Net Cash Flow | $-3,874 | $3,775 | $-235 | $3,575 | $6,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,674 | 4,683 | 578 | 4,188 | -1,318 |
| Capital Expenditure | -1,282 | -857 | -770 | -598 | -1,149 |
| Free Cash Flow | 7,392 | 3,826 | -192 | 3,590 | -2,467 |